Novo Nordisk

Novo Nordisk Files For FDA Approval Of Higher-Dose Semaglutide

Novo Nordisk Files For FDA Approval Of Higher-Dose Semaglutide

29 Nov 2025

1 min read

Weight-loss Drug Semaglutide Falls Short In Alzheimer’s Treatment Test

Weight-loss Drug Semaglutide Falls Short In Alzheimer’s Treatment Test

25 Nov 2025

1 min read

Novo Nordisk Partners with Emcure to Expand Access to Weight-Loss Drug Poviztra in India

Novo Nordisk Partners with Emcure to Expand Access to Weight-Loss Drug Poviztra in India

11 Nov 2025

1 min read

Read More

Voice Of HealthCare

vohnetwork.com